Condition: IBS - Irritable Bowel Syndrome · Sucrase-Isomaltase Deficiency · Sponsor: Region Skane
The goal of this interventional study is to examine whether those patients with irritable bowel syndrome (IBS) and a reduced abitility do degrade starch and sugar (lowe levels of enzymes) have lower raise in blood glucose after a meal than those with normal expression of enzymes. We also want to examine whether those IBS patients with reduced enzyme levels have increased bowel symptom in relation to this meal. The main questions it aims to answer are: Does reduced ability to degrade starch and sugar due to less enzyme activity lead to lower increase in blood glucose after a meal? Does reduced ability to degrade starch and sugar due to less enzyme activity lead to increased bowel symptoms after a meal?
This description comes directly from the study's public registry record.
Bodil Ohlsson C Professor, MD, PhD · +46+402712660 · bodil.ohlsson@med.lu.se
Mauro D'Amato Professor · mdamato@cicbiogune.es
Always discuss trial participation with your own doctor first.
| Skåne University Hospital | Malmö, Skåne County, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07309601